ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab

American Journal of Transplantation

Volumn 5, Issue 1, 2005, Pages 145-148

  Tydén, Gunnar ^a   Kumlien, Gunilla ^a   Genberg, Helena ^a   Sandberg, John ^a   Lundgren, Torbjörn ^a   Fehrman, Ingela ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ABO incompatible; Antigen specific; Immunoadsorption; Rituximab

Indexed keywords

15 DEOXYSPERGUALIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS; VALACICLOVIR; VALGANCICLOVIR;

ANTIGEN SPECIFICITY; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; SPLENECTOMY;

ABO BLOOD-GROUP SYSTEM; ADSORPTION; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; CREATININE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; SPLENECTOMY; TACROLIMUS; TIME FACTORS; TRANSPLANTATION CONDITIONING;

EID: 11844276631     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00653.x     Document Type: Article

References (10)

1. Alexandre GP, Squifflet JP, De Bruyere M et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19(6): 4538-4542.
2. Slapak M, Digard N, Ahmed M, Shell T, Thompson F. Renal transplantation across the ABO barrier-A 9-year experience. Transplant Proc 1990; 22(4): 1425-1428.
3. Gloor JM, Lager DJ, Moore SB et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75(7): 971-977.
4. Tanabe K, Takahashi K, Sonda K et al. Long-term results of ABO-incompatible living kidney transplantation: A single-center experience. Transplantation 1998; 65(2): 224-228.
5. Tydén G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76(4): 730-743.
6. Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Toma H. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000; 70: 1331-1335.
7. Rydberg L. ABO-incompatibility in s.olid organ transplantation. Transfus Med 2001; 11: 325-342.
8. Vieira CA, Agarwal A, Book BK et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation 2004; 77(4): 542-548.
9. Jordan SC. Management of the highly HLA-sensitized patient: A novel role for intravenous gammaglobulin. Am J Transplant 2002; 2: 691-692.
10. Tydén G, Sandberg J, Elinder C-G, Berg U. Successful transplantation of two children with antiendothelial cell antibodies. Transplant Proc 2003; 35: 792-793.